-
About UsBeijing Northland Biotechnology Co., Ltd. is an innovative biopharmaceutical company specializing in the research, development, production, and sales of gene therapy drugs, recombinant protein drugs, and ophthalmic drugs. -
R&D and ProductsPrimarily dedicated to the research, development, and industrialization of novel bioengineered drugs in areas such as cardiovascular diseases, metabolic disorders, rare diseases, and ophthalmic diseases. -
Investor RelationsGuided by the principle of “Creating Value, Serving Health,” the company is committed to becoming an innovative biopharmaceutical enterprise, contributing to the advancement of China’s pharmaceutical industry and the well-being of humanity.
NORTHLAND Receives Support from the "Special Fund for International Development of Small and Medium-sized Enterprises"
The website of the Haidian Park Management Committee of the Zhongguancun Science and Technology Park announced that NORTHLAND’s NL003 project has been selected for the 2006 “Haidian Park Special Development Fund—Special Fund for the Internationalization of Small and Medium-Sized Enterprises” program. The Haidian Park Management Committee conducted a rigorous review of the projects submitted by companies in the park for 2006. Following approval by the Haidian Park Management Committee’s departmental office meeting, a total of 30 companies in the park received support this time, with a total funding amount of 4.9 million yuan.
Share to:
Friendly Links: Baidu | NORTHLAND
Contact Information
Address: Room A406, Zhongguancun Biomedical Park, No. 5 Kaituo Road, Shangdi, Haidian District, Beijing
Follow Us
Northland is an innovative biopharmaceutical company specializing in the R&D, manufacturing and sales of gene therapy drugs, recombinant protein drugs and ophthalmic medications.
Web site
NL-BIO
NL003
NL005